Top in women’s health: Med students weigh state abortion laws; rising OB/GYN competition
Click Here to Manage Email Alerts
A recent survey of medical students indicated most were unlikely to apply to any residency programs in states with abortion restrictions, which researchers said are now a “key factor” for many in the wake of the Dobbs decision.
“We found it interesting that medical students applying to every specialty, not just OB/GYN, are influenced by Dobbs and subsequent abortion restrictions when choosing where to apply to residency,” Ariana M. Traub, MPH, and Kellen Mermin-Bunnell, BS, third-year medical students at Emory University School of Medicine, told Healio.
It was the top story in women’s health last week.
Another top story covered a longitudinal analysis of OB/GYN residencies that registered an uptick in competitiveness over the last 2 decades. Researchers found significant increases from 2003 to 2022 in both total OB/GYN positions (1,172.6 vs. 1,344.6) and total applicants (1,539 vs. 1,902), with applicants increasing at a higher rate than positions.
Read these and more top stories in women’s health below:
State abortion laws influencing many medical students’ residency choices
A new study found that the Dobbs decision and subsequent restrictive abortion laws are impacting residency application decisions for medical students across all specialties. Read more.
OB/GYN program competitiveness significantly increased over the last 20 years
From 2003 to 2022, findings presented at the ACOG Annual Clinical & Scientific Meeting found a significant increase in competitiveness in OB/GYN residency programs. Read more.
Q&A: Breastfeeding has beneficial effects on cardiometabolic health
Breastfeeding has lasting beneficial effects on cardiometabolic health, including lowering the risk for type 2 diabetes and CVD, for mothers and obesity in their children, according to a life course epidemiologist. Read more.
COVID-19 during pregnancy may predict worse birth outcomes
SARS-CoV-2 infection during pregnancy predicted worse birth outcomes, including preterm delivery, low birthweight and longer hospital stay, data show. Read more.
Cabergoline effective for preventing breast symptoms after abortion, pregnancy loss
A one-time dose of off-label cabergoline after second-trimester abortion or pregnancy loss was effective for preventing symptomatic breast engorgement, according to data presented at the ACOG Annual Clinical & Scientific Meeting. Read more.